Side-by-side comparison of AI visibility scores, market position, and capabilities
San Mateo healthcare AI platform automating patient intake, insurance verification, care gap identification, and post-visit follow-up for health systems via EHR-connected AI agents.
Notable Health is a San Mateo-based healthcare AI company that provides health systems with an automation platform that handles repetitive clinical and administrative tasks — patient intake, pre-visit questionnaires, insurance verification, care gap identification, and post-visit follow-up — using AI agents deployed on health system infrastructure. Notable's platform connects to EHR systems to understand each patient's care context and proactively sends personalized communications and automated workflows at the right moments in the patient journey. By automating tasks that currently consume significant time from nurses, medical assistants, and front desk staff, Notable enables health systems to manage the same patient volume with fewer administrative staff or improve throughput without hiring. The company has documented millions of automated care actions with customers including Intermountain Health and Stanford Medicine. Founded in 2017, Notable raised over $100M from investors including F-Prime Capital, BOND, and Oak HC/FT, and competes with Olive AI (now closed) and Regard in the healthcare automation market.
Regeneron (REGN) reported $13.9B revenue in FY2024, up 7% YoY. Top biotech company. Dupixent franchise >$14B. Leaders in eye disease, immunology, oncology. HQ: Tarrytown, NY.
Regeneron Pharmaceuticals, Inc. is a leading biotechnology company specializing in the discovery, development, and commercialization of medicines for serious diseases, headquartered in Tarrytown, New York. Founded in 1988 by Leonard Schleifer and George Yancopoulos, Regeneron developed its own proprietary drug discovery technology platform (VelociGene, VelocImmune) that has enabled the development of multiple breakthrough medicines. The company reported revenues of $13.9B in FY2024, up 7% year-over-year.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.